a public good project by the
Synthesis
Company
of California

© 2026

Julien Lesage | doi.page

0 works0 citations0 h-index

Julien Lesage

Washington University in St. Louis(US)Cancer Australia(AU)Lille Inflammation Research International Center(FR)Patient Advocate Foundation(US)Institute for Translational Research in Inflammation

Publications by Year

Research Areas

Ferroptosis and cancer prognosis, Clusterin in disease pathology, Cancer, Lipids, and Metabolism, Cancer-related gene regulation, Lung Cancer Diagnosis and Treatment

Most-Cited Works

→ EMT and inflammation: inseparable actors of cancer progression(2017)574 cited
→ Soluble factors regulated by epithelial–mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitment(2015)73 cited
→ Cystic fibrosis airway epithelium remodelling: involvement of inflammation(2014)71 cited
→ Zonula occludens‐1/NF‐κB/CXCL8: a new regulatory axis for tumor angiogenesis(2017)31 cited
→ ZO-1 Intracellular Localization Organizes Immune Response in Non-Small Cell Lung Cancer(2021)12 cited
→ Impacts of a Clinical Quality Registry on Lung Cancer Quality Measures: A Retrospective Observational Study of the Victorian Lung Cancer Registry(2025)6 cited

→ DDR2 Confers Ferroptosis Resistance to Cancer-Associated Fibroblasts and Attenuates PARPi Sensitivity of Ovarian Tumor Cells(2025)

3 cited

→ Supplementary Table 1 from DDR2 Confers Ferroptosis Resistance to Cancer-Associated Fibroblasts and Attenuates PARPi Sensitivity of Ovarian Tumor Cells(2025)

Implication des Zonula Occludens dans la progression métastatique des cancers broncho-pulmonaires(2016)

→ Supplementary Figure S7 from DDR2 Confers Ferroptosis Resistance to Cancer-Associated Fibroblasts and Attenuates PARPi Sensitivity of Ovarian Tumor Cells(2025)